| Chryselle Nazare, MD | |
|
9 Chatham Ctr S Ste C, Savannah, GA 31405-7455 | |
| (912) 527-7211 | |
| (912) 527-7222 |
| Full Name | Chryselle Nazare |
|---|---|
| Gender | Female |
| Speciality | Hospitalist |
| Experience | 17 Years |
| Location | 9 Chatham Ctr S Ste C, Savannah, Georgia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1912167578 | NPI | - | NPPES |
| 618947 | Other | GA | WELLCARE |
| P00949152 | Other | GA | RAILROAD MEDICARE |
| 003110517A | Medicaid | GA | |
| 01438428 | Other | AMERIGROUP | |
| GA1207 | Medicaid | SC |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 066389 (Georgia) | Secondary |
| 207R00000X | Internal Medicine | 066389 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Joseph's Hospital - Savannah | Savannah, GA | Hospital |
| Candler Hospital | Savannah, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Privia Medical Group Of Georgia Llc | 4284951542 | 301 |
News Archive
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.
New research reveals that children born to women with rheumatoid arthritis face an increased susceptibility for certain chronic diseases. The findings, which appear in Arthritis Care & Research, should be used to increase awareness among pediatricians and general practitioners.
Alexion Pharmaceuticals, Inc. today announced financial results for the three and six months ended June 30, 2012.
› Verified 7 days ago
| Entity Name | Cogent Healthcare Of Georgia Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1609827823 PECOS PAC ID: 2961483607 Enrollment ID: O20040527000856 |
News Archive
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.
New research reveals that children born to women with rheumatoid arthritis face an increased susceptibility for certain chronic diseases. The findings, which appear in Arthritis Care & Research, should be used to increase awareness among pediatricians and general practitioners.
Alexion Pharmaceuticals, Inc. today announced financial results for the three and six months ended June 30, 2012.
› Verified 7 days ago
| Entity Name | Privia Medical Group Of Georgia Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1013313857 PECOS PAC ID: 4284951542 Enrollment ID: O20150325000983 |
News Archive
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.
New research reveals that children born to women with rheumatoid arthritis face an increased susceptibility for certain chronic diseases. The findings, which appear in Arthritis Care & Research, should be used to increase awareness among pediatricians and general practitioners.
Alexion Pharmaceuticals, Inc. today announced financial results for the three and six months ended June 30, 2012.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Chryselle Nazare, MD Po Box 15849, Savannah, GA 31416-2549 Ph: (912) 303-3552 | Chryselle Nazare, MD 9 Chatham Ctr S Ste C, Savannah, GA 31405-7455 Ph: (912) 527-7211 |
News Archive
The use of an oral anticoagulant medicine in medically ill patients for 45 days following their discharge from the hospital reduces the rate of non-fatal symptomatic blood clots with no impact on fatal blood clots, according to late breaking results from the MARINER trial presented today in a Hot Line Session at ESC Congress 2018 and published in The New England Journal of Medicine.
Scripps Research, a globally recognized nonprofit biomedical research institute, today announced a collaborative research program with Tempus, a leader in precision medicine and artificial intelligence, to develop a predictive model of glucose responses in people with and without type 2 diabetes.
New research reveals that children born to women with rheumatoid arthritis face an increased susceptibility for certain chronic diseases. The findings, which appear in Arthritis Care & Research, should be used to increase awareness among pediatricians and general practitioners.
Alexion Pharmaceuticals, Inc. today announced financial results for the three and six months ended June 30, 2012.
› Verified 7 days ago
Florin C Georgescu, M. D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 E 66th St, Savannah, GA 31405 Phone: 912-356-5643 Fax: 912-356-9712 | |
James A Daly Iii, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 340 Hodgson Ct, Suite 2, Savannah, GA 31406 Phone: 912-629-2290 Fax: 912-629-2291 | |
Elizabeth Florence Cornell, DO Internal Medicine Medicare: May Accept Medicare Assignments Practice Location: 6602 Waters Ave Bldg A, Savannah, GA 31406 Phone: 912-350-6000 Fax: 912-350-6001 | |
Dr. Kinhtu Lien, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 4700 Waters Ave, Savannah, GA 31404 Phone: 912-350-7573 | |
Dr. Barry James Krakow, MD Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 211 Early St, Savannah, GA 31405 Phone: 505-238-7519 | |
Dr. John David Northup, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 12345 Mercy Blvd, Savannah, GA 31419 Phone: 912-927-3046 Fax: 912-925-0597 | |
Samuel David Patrick Mcelroy, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 4451 Paulsen St, Savannah, Savannah, GA 31405 Phone: 912-350-7500 Fax: 912-350-7735 |